脊髓室管膜下细胞型室管膜瘤的临床特征与手术结局:40例报告
单中心回顾分析2009年4月至2016年5月北京天坛医院约4000例脊髓肿瘤中病理证实的40例室管膜下细胞型室管膜瘤(约占1%),平均年龄40.0岁,中位随访43个月,1年与5年无进展生存率分别为100.0%和97.5%,仅1例复发、无肿瘤相关死亡。
要点
- 脊髓室管膜下细胞型室管膜瘤约占脊髓肿瘤的1%,复发率低,长期生存可期。
- 肿瘤边界不清与术前JOA评分<14显著限制肿瘤切除程度。
- 不建议以严重神经功能缺损为代价追求肿瘤根治性切除。
核心结论
- 脊髓室管膜下细胞型室管膜瘤是室管膜瘤的罕见亚型,复发率低,长期生存可期,但肿瘤边界不清是长期结局的独立预测因素。
- 由于肿瘤边界不清且包绕关键神经血管结构,脊髓室管膜下细胞型室管膜瘤的显微外科治疗仍是巨大挑战。
- 不建议以严重神经功能缺损为代价行根治性肿瘤切除。
研究设计与样本
- 回顾性分析北京天坛医院2009年4月至2016年5月手术切除的约4000例脊髓肿瘤中病理证实的40例室管膜下细胞型室管膜瘤。
- 患者平均年龄40.0岁,男性21例、女性19例,无显著性别倾向。
- 肿瘤最大径中位54.2 mm(范围16-153 mm),术前JOA评分平均13.0。
主要发现
- 室管膜下细胞型室管膜瘤约占脊髓肿瘤的1%(约4000例中40例)。
- 影像学上47.5%(19/40)病例肿瘤边界不清,40%(16/40)术前合并脊髓空洞。
- 全切除30例、次全切除8例、部分切除2例。
- 出院时JOA评分及神经功能改善26例(65%)、无变化12例(30%)、恶化2例(5%)。
- 中位随访43个月(范围7-101个月),1年与5年无进展生存率分别为100.0%和97.5%,仅1例于术后30个月发现肿瘤复发,无患者死于肿瘤复发。
关键数值与推荐
- 随访末次时JOA评分改善30例(75%)、无变化8例(20%)、恶化2例(5%)。
- 单因素分析显示肿瘤大小和术前JOA评分与短期结局显著相关。
- 年龄≥40岁、肿瘤大小≥50 mm、非全切除及术前JOA评分<14与长期结局恶化风险增加显著相关。
- 肿瘤边界不清和术前JOA评分<14显著限制肿瘤切除程度。
临床怎么用
- 作者认为,脊髓室管膜下细胞型室管膜瘤因边界不清且包绕关键神经血管结构,显微手术仍是巨大挑战。
- 作者认为,不建议以严重神经功能缺损为代价追求根治性肿瘤切除。
- 原文未据此给出其他推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Spinal cord tanycytic ependymomas (TEs) rarely are reported because of extremely low incidence. Understanding of this disease is therefore poor. The aim of this study was to analyze the incidence and clinical, radiologic, pathologic, and prognostic features of spinal cord TEs. METHODS: Approximately 4000 spinal cord tumors were resected surgically in Beijing Tiantan Hospital between April 2009 and May 2016. We identified all cases of pathologically proved TEs among these patients. RESULTS: TEs accounted for approximately 1% of spinal cord tumors (40 of an estimated 4000). Patients with TE were a mean age of 40.0 years and had no significant sex preference (21 male and 19 female). The median diameter of the maximal tumor was 54.2 mm (range, 16-153 mm). The mean preoperative Japanese Orthopedic Association (JOA) score was 13.0. Radiologically, 47.5% (19/40) cases showed poorly defined tumor border, and 40% (16/40) of them showed preoperative syringomyelia. Gross total resection was achieved in 30 cases, subtotal resection in 8, and partial resection in 2. At the time of discharge, JOA score and neurologic function showed improvement in 26 cases (65%), no change in 12 cases (30%), and worsening in 2 cases (5%). At a median follow-up of 43 months (range, 7-101 months), 1- and 5-year progression-free survival rates were 100.0% and 97.5%, respectively. Only one patient had tumor recurrence which was found 30 months after surgery. No patient died of tumor recurrence. At the latest follow-up, JOA score showed improvement in 30 cases (75%), no change in 8 cases (20%), and worsening in 2 cases (5%). Univariate analysis revealed that tumor size and preoperative JOA score were significantly associated with the short-term outcomes. Meanwhile, age ≥40 years, tumor size ≥50 mm, non-gross total resection, and preoperative JOA score <14 were significantly associated with an increased risk of worsened long-term outcomes. Poorly defined tumor border and preoperative JOA score <14 significantly limited the extent of tumor resection. CONCLUSIONS: Spinal cord TE is a rare subtype of ependymomas with low recurrence. Long-term survival can be expected, although poorly defined tumor border is an independent predictor of long-term outcomes. Microsurgical treatment of spinal cord TEs remains a formidable challenge due to the poorly defined border and critical neurovascular structures encasement. It is unnecessary for radical tumor resection at the cost of severe neurologic deficits.
引用
- Tao X, Hou Z, Hao S, et al. The Clinical Features and Surgical Outcomes of Spinal Cord Tanycytic Ependymomas: A Report of 40 Cases. World Neurosurg. 2017. PMID: 28647654. doi:10.1016/j.wneu.2017.06.111
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。